OPILL Trademark

Trademark Overview

On Thursday, September 7, 2023, a trademark application was filed for OPILL with the United States Patent and Trademark Office. The USPTO has given the OPILL trademark a serial number of 98169254. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Monday, April 14, 2025. This trademark is owned by Laboratoire HRA Pharma SAS. The OPILL trademark is filed in the Pharmaceutical Products category with the following description:

Oral contraceptives
opill

General Information

Serial Number98169254
Word MarkOPILL
Filing DateThursday, September 7, 2023
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateMonday, April 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements

Description of MarkThe mark consists of the word "OPILL" in a blue stylized font.
Goods and ServicesOral contraceptives
Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 7, 2023
Primary Code005
First Use Anywhere DateMonday, March 18, 2024
First Use In Commerce DateMonday, March 18, 2024

Trademark Owner History

Party NameLaboratoire HRA Pharma SAS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressChatillon 92320
FR
Party NameLaboratoire HRA Pharma SAS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChatillon 92320
FR

Trademark Events

Event DateEvent Description
Thursday, September 7, 2023NEW APPLICATION ENTERED
Sunday, November 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 2, 2024ASSIGNED TO EXAMINER
Wednesday, May 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 28, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, July 30, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, July 18, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, July 30, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 30, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, July 30, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 30, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, October 15, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 13, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 13, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 13, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, January 13, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 4, 2025USE AMENDMENT FILED
Tuesday, February 4, 2025TEAS STATEMENT OF USE RECEIVED
Monday, April 14, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, April 14, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

opill contraceptives oral